Treatment News : HIV-Specific Poison May Complement ARVs

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 10, 2014

HIV-Specific Poison May Complement ARVs

A study conducted in mice has shown that a toxin engineered to target HIV can eliminate infected immune cells in which the virus is replicating despite antiretroviral (ARV) therapy. This finding suggests that the toxin, called 3B3-PE38 and developed in 1998 in NIH labs, may one day serve as an adjunct to ARVs.

Publishing their findings in PLOS Pathogens, researchers at the University of North Carolina and the National Institutes of Health (NIH) took 40 mice with bioengineered human immune systems and infected them with HIV. Several months later, the mice received a combination of ARVs for four weeks, after which point half of them were given two weeks of 3B3-PE38 in addition to the ARVs and the other half just received the ARVs.

When compared with the control group, those who received the HIV-specific toxin saw a significant drop in both the number of HIV-infected cells producing virus in various organs and in blood viral load.

The researchers speculate that using 3B3-PE38 as a complement to ARVs may one day help people living with HIV achieve a sustained disease remission—either controlling or eliminating the virus without the need for indefinite ARV treatment.

To read the NIH release, click here.

To read the study, click here.

Search: HIV, poison, toxin, antiretrovirals, National Institutes of Health, NIH, 3B3-PE38, PLOS Pathogens, University of North Carolina, mice.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 1 - 4 (of 4 total)    

david, kampala, 2014-01-23 12:35:33
science and research is for those who are patient please keepit up.

Robert, Atlanta, 2014-01-22 13:42:15
I agree with emo's comment. I'm so sick and tired of hearing about studies that MAY one day, do this or do that. Just once, I'd love to hear about a drug study that seeks out hidden or latent infected T-Cells, and KILLS the damn things; leading to virus eradication! My "bitter" take on all of this is that researchers and scientists are more interested publishing reports, and EVEN MORE SO in the grant monies generated for HIV/AIDS research, than they are for actually finding a cure.

Trwms36, Queens, 2014-01-22 10:28:21
I remember a similar storu published in the Time Picayune in New Orleans, La back in 2003. Thanks for showing us they didn't give up on the reseatch eventhough the article mentioned the concoction didn't work for everyone.

emo, DC, 2014-01-11 05:39:43
OK OK.is it another successful experiment which we are not ever gonna hear for another 15 plus years or is this just some news for the scientist to get more funds?i think it is gonna be just another story which is gonna fade away.

comments 1 - 4 (of 4 total)    


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.